Article
The triple combination of Remdesivir (GS-441524), Molnupiravir and Ribavirin is highly…
medRxiv · 2024 · Do, T. N. D.; Abdelnabi, R.; Boda, B.; Constant, S.; Neyts, J.; Jochmans, D.
Key facts
| Title | The triple combination of Remdesivir (GS-441524), Molnupiravir and Ribavirin is highly efficient in inhibiting coronavirus replication in human nasal airway epithelial cell cultures and in a hamster infection model |
|---|---|
| First author | Do, T. N. D.; Abdelnabi, R.; Boda, B.; Constant, S.; Neyts, J.; Jochmans, D. |
| Journal | medRxiv |
| Published | Jan 1, 2024 |
| DOI | 10.1101/2024.05.14.594200 |
| Devices mentioned | 204445 |
| Product codes mentioned | JJH |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1